Codexis, Inc. (CDXS)
NASDAQ: CDXS · Real-Time Price · USD
4.180
-0.080 (-1.88%)
At close: Feb 21, 2025, 4:00 PM
4.250
+0.070 (1.67%)
After-hours: Feb 21, 2025, 6:00 PM EST
Codexis Market Cap
Codexis has a market cap or net worth of $340.16 million as of February 21, 2025. Its market cap has increased by 69.74% in one year.
Market Cap
340.16M
Enterprise Value
291.75M
1-Year Change
69.74%
Ranking
Category
Stock Price
$4.18
Market Cap Chart
Since April 22, 2010, Codexis's market cap has decreased from $449.60M to $340.16M, a decrease of -24.34%. That is a compound annual growth rate of -1.86%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Feb 21, 2025 | 340.20M | -12.36% |
Dec 31, 2024 | 388.20M | 82.25% |
Dec 29, 2023 | 213.00M | -30.41% |
Dec 30, 2022 | 306.10M | -84.91% |
Dec 31, 2021 | 2.03B | 56.76% |
Dec 31, 2020 | 1.29B | 38.30% |
Dec 31, 2019 | 935.70M | 3.72% |
Dec 31, 2018 | 902.10M | 123.46% |
Dec 29, 2017 | 403.70M | 112.92% |
Dec 30, 2016 | 189.60M | 11.20% |
Dec 31, 2015 | 170.50M | 71.01% |
Dec 31, 2014 | 99.70M | 87.05% |
Dec 31, 2013 | 53.30M | -35.78% |
Dec 31, 2012 | 83.00M | -56.43% |
Dec 30, 2011 | 190.50M | -47.49% |
Dec 31, 2010 | 362.80M | -19.31% |
View and export this data all the way back to 2010.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 784.71B |
UnitedHealth Group | 429.24B |
Novo Nordisk | 391.83B |
Johnson & Johnson | 390.76B |
AbbVie | 356.74B |
Abbott Laboratories | 234.01B |
AstraZeneca | 229.50B |
Merck & Co. | 226.40B |